Valbiotis (XPAR:ALVAL) ROE % Adjusted to Book Value: -43.70% (As of Dec. 2025)


XPAR:ALVAL Valbiotis SA XPAR:ALVAL
55 GF Score
Price €0.75
GF Value €1.49
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Valbiotis ROE % Adjusted to Book Value?

Valbiotis XPAR:ALVAL -7.22% 55 ROE % Adjusted to Book Value is -43.70% as of Dec. 2025. GuruFocus rates XPAR:ALVAL with a GF Score™ of 55/100 and a GF Value™ of €1.49 (Possible Value Trap). The stock has 6 warning signs investors should review.

Valbiotis's ROE % for the quarter that ended in Dec. 2025 was -103.13%. Valbiotis's PB Ratio for the quarter that ended in Dec. 2025 was 2.36. Valbiotis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -43.70%.

Valbiotis ROE % Adjusted to Book Value Related Terms

Valbiotis ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Valbiotis's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valbiotis ROE % Adjusted to Book Value Chart

Valbiotis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.37 -26.66 -11.12 -28.96 -46.05

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.31 -37.71 -41.51 -52.57 -43.70

XPAR:ALVAL vs KHC, GIS: ROE % Adjusted to Book Value Comparison

For the Packaged Foods subindustry, Valbiotis's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valbiotis ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Valbiotis's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Valbiotis's ROE % Adjusted to Book Value falls into.


XPAR:ALVAL
55GF Score
Valbiotis SA XPAR:ALVAL
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valbiotis ROE % Adjusted to Book Value Calculation

Valbiotis's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-108.68% / 2.36
=-46.05%

Valbiotis's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-103.13% / 2.36
=-43.70%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -43.70% mean?
Valbiotis (XPAR:ALVAL) has a ROE % Adjusted to Book Value of -43.70% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Valbiotis and its competitors.
Is Valbiotis' ROE % Adjusted to Book Value too high?
Valbiotis' current ROE % Adjusted to Book Value is -43.70%. Overall, Valbiotis has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valbiotis' ROE % Adjusted to Book Value compare to KHC and GIS?
Valbiotis' ROE % Adjusted to Book Value of -43.70% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Valbiotis and its competitors. Valbiotis's current ROE % Adjusted to Book Value is -43.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valbiotis stock overvalued right now?
Based on GuruFocus' analysis, Valbiotis (XPAR:ALVAL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.49, compared to a current price of €0.75 — trading 50% below its estimated fair value. The current ROE % Adjusted to Book Value is -43.70%. Valbiotis' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Valbiotis (XPAR:ALVAL), the current ROE % Adjusted to Book Value is -43.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valbiotis (XPAR:ALVAL) Overvalued in 2026?

Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued. The current stock price of €0.75 is trading 50% below its estimated GF Value™ of €1.49. GuruFocus considers Valbiotis to be Possible Value Trap.

Key valuation signals for XPAR:ALVAL:

  • ROE % Adjusted to Book Value: -43.70%
  • GF Value™: €1.49 vs. price of €0.75 (50% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the XPAR:ALVAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valbiotis Business Description

Other Exchanges 8JD:Germany
Address 12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
55GF Score

Get the complete analysis for XPAR:ALVAL

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€1.49
GF Value